| Schedule of segment reporting information |
Information with respect
to these reportable business segments for the three months ended March 31, 2018 and 2017 was as follows:
| |
|
Three Months Ended
March 31, 2018
|
|
|
Three Months Ended
March 31, 2017
|
|
| Revenues |
|
|
|
|
|
|
| Real property operating |
|
$ |
296,623 |
|
|
$ |
— |
|
|
| Development services and sales of developed products |
|
|
11,290 |
|
|
|
— |
|
|
| Medical related consulting services – related party |
|
|
— |
|
|
|
66,286 |
|
|
| |
|
|
307,913 |
|
|
|
66,286 |
|
|
| Depreciation and amortization |
|
|
|
|
|
|
|
|
|
| Real property operating |
|
|
32,624 |
|
|
|
— |
|
|
| Development services and sales of developed products |
|
|
86,749 |
|
|
|
— |
|
|
| Medical related consulting services – related party |
|
|
4,006 |
|
|
|
26 |
|
|
| |
|
|
123,379 |
|
|
|
26 |
|
|
| Interest expense |
|
|
|
|
|
|
|
|
|
| Real property operating |
|
|
236,986 |
|
|
|
— |
|
|
| Development services and sales of developed products |
|
|
— |
|
|
|
— |
|
|
| Medical related consulting services – related party |
|
|
— |
|
|
|
— |
|
|
| |
|
|
236,986 |
|
|
|
— |
|
|
| Net loss |
|
|
|
|
|
|
|
|
|
| Real property operating |
|
|
(237,700 |
) |
|
|
— |
|
|
| Development services and sales of developed products |
|
|
(173,474 |
) |
|
|
— |
|
|
| Medical related consulting services |
|
|
(100,132 |
) |
|
|
(549,333 |
) |
|
| Other (a) |
|
|
(1,039,663 |
) |
|
|
— |
|
|
| |
|
$ |
(1,550,969 |
) |
|
$ |
(549,333 |
) |
|
| Identifiable long-lived tangible assets at March 31, 2018 and December 31, 2017 |
|
March 31, 2018 |
|
|
December 31, 2017 |
|
| Real property operating |
|
$ |
7,612,747 |
|
|
$ |
7,645,371 |
|
| Development services and sales of developed products |
|
|
120,396 |
|
|
|
5,857 |
|
| Medical related consulting services |
|
|
17,224 |
|
|
|
20,558 |
|
| |
|
$ |
7,750,367 |
|
|
$ |
7,671,786 |
|
| Identifiable long-lived tangible assets at March 31, 2018 and December 31, 2017 |
|
March 31, 2018 |
|
|
December 31, 2017 |
|
| United States |
|
$ |
7,613,567 |
|
|
$ |
7,646,270 |
|
| China |
|
|
136,800 |
|
|
|
25,516 |
|
| |
|
$ |
7,750,367 |
|
|
$ |
7,671,786 |
|
| |
(a) |
The Company does not allocate any general and administrative expense of its being a public company activities to its reportable segments as these activities are managed at a corporate level. |
|